Surgical Mesh Implants Market Report 2025

The surgical mesh implants market size has grown strongly in recent years. It will grow from $3.71 billion in 2024 to $3.97 billion in 2025 at a compound annual growth rate (CAGR) of 7%. The growth during the historic period can be credited to several factors, including the rising incidence of hernia and pelvic organ prolapse, a growing preference for minimally invasive procedures, greater awareness of the advantages of surgical mesh, an aging population more susceptible to soft tissue injuries, and ongoing technological improvements in mesh materials.

The surgical mesh implants market size is expected to see strong growth in the next few years. It will grow to $5.13 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth during the forecast period can be linked to the growing use of bioabsorbable and composite meshes, increased investment in research and development, a shift toward outpatient and ambulatory procedures, expanding demand in emerging markets, and a rise in regulatory approvals for novel mesh products. Key trends expected during this period include progress in bioabsorbable mesh technology, the development of advanced composite and hybrid mesh designs, innovations in minimally invasive surgical methods, enhancements in antibacterial and anti-adhesive coatings, and the emergence of smart, sensor-integrated surgical meshes.

The increasing number of hernia cases is contributing significantly to the expansion of the surgical mesh implants market. A hernia occurs when an internal organ or tissue pushes through a weakened area in the muscle or connective tissue. This rise in cases is largely attributed to the aging population, as older individuals often experience weakened abdominal muscles and multiple health issues, making them more prone to hernias. Surgical mesh implants play a vital role in treating these conditions by reinforcing damaged tissue, helping prevent recurrence, and supporting faster, more effective healing. For example, data from Eurostat in July 2024 showed that inguinal hernia repairs were conducted between 142 and 231 times per 100,000 people in 2022, with Austria reporting a notably high rate of 273.2 per 100,000. This growing incidence of hernias is therefore fueling market growth for surgical mesh implants.

Key players in the surgical mesh implants sector are focusing on technological advancements, particularly in the development of fully bioabsorbable meshes. These innovations aim to improve patient recovery, reduce long-term complications, and respond to the demand for temporary implant solutions. Fully bioabsorbable meshes are made from materials that naturally break down and are absorbed by the body, eliminating the need for permanent implantation. In April 2025, Becton, Dickinson and Company, a U.S.-based pharmaceutical firm, received FDA 510(k) clearance and commercially launched the Phasix ST Umbilical Hernia Patch in the U.S. This is the first and only fully absorbable mesh specifically designed for umbilical hernia repair. Made from bioabsorbable polymer, the patch dissolves within the body over time, offering a non-permanent and patient-friendly treatment option that aligns with evolving clinical needs.

In February 2024, RTI Surgical Inc., a U.S.-based contract development and manufacturing organization, completed the acquisition of Cook Biotech Inc. for an undisclosed amount. With this acquisition, RTI Surgical aims to become the only regenerative medicine CDMO capable of producing both allograft and xenograft biomaterials on a large scale. This strategic move strengthens its leadership in soft tissue applications and expands its market reach. Cook Biotech Inc. is a U.S.-based company, specializes in regenerative medicine and manufactures biologic mesh products for hernia repair.

Major players in the surgical mesh implants market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, W. L. Gore & Associates Inc., Cook Medical, Integra LifeSciences Corporation, Ethicon Inc., B. Braun Melsungen AG, Feg Textiltechnik mbH, Cousin Biotech, Proxy Biomedical Ltd., Betatech Medical, Dipromed Srl, Novus Scientific Pte. Ltd., Atrium Medical Corporation, LifeCell Corporation, Hernia Mesh S.R.L., and THT Bio-Science Inc.

North America was the largest region in the surgical mesh implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in surgical mesh implants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the surgical mesh implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The surgical mesh implants market consists of sales of plug mesh, coated mesh, lightweight mesh, and heavyweight mesh. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The surgical mesh implants market research report is one of a series of new reports that provides surgical mesh implants market statistics, including the surgical mesh implants industry global market size, regional shares, competitors with the surgical mesh implants market share, detailed surgical mesh implants market segments, market trends, and opportunities, and any further data you may need to thrive in the surgical mesh implants industry. This surgical mesh implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Surgical mesh implants are medical devices made from either synthetic or biological materials, used to provide additional support to weakened or damaged tissue during surgical procedures. These implants are commonly used in soft tissue reinforcement surgeries and other similar procedures, helping to promote tissue growth and healing while restoring structural integrity.

The primary types of surgical mesh implants include non-absorbable surgical mesh, absorbable surgical mesh, and other variations. Non-absorbable surgical mesh is made from synthetic materials that remain permanently in the body to offer long-term support to weakened or damaged tissue. Surgical procedures employing these meshes include laparoscopic surgery, open surgery, robotic-assisted surgery, and endoscopic surgery. Materials used in surgical mesh implants include polypropylene, polyester, polytetrafluoroethylene, and others. These meshes are applied in various medical procedures such as hernia repair, pelvic organ prolapse repair, and gastroesophageal reflux disease (GERD) repair. They are used by several end users, including hospitals, ambulatory surgical centers (ASCs), specialized clinics, and research institutions.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.